Author | Markus Renschler, MD | OncLive

Author | Markus Renschler, MD

Articles

Dr. Renschler Discusses Updated Results of the MPACT Study

June 20, 2014

Video

Markus Renschler, MD, vice president, global head, Hematology Oncology Medical Affairs at Celgene, discusses updated results of the MPACT study, which examined nab-paclitaxel plus gemcitabine vs gemcitabine for patients with metastatic pancreatic cancer.

x